🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted action to deal with cost of living pressures" in the upcoming financial statement.

During an interview with media outlets, she emphasized that reducing price rises is a joint duty of both the administration and the central bank.

The UK's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Possible Energy Bill Interventions

Reports indicate the government could intervene to lower energy bills, for example by cutting the current 5% rate of value-added tax applied on energy supplies.

An additional possibility is to reduce some of the government charges presently included in bills.

Fiscal Constraints and Expert Predictions

The administration will receive the next assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such measures.

The view from the majority of economists is that Reeves will have to introduce higher taxes or budget cuts in order to meet her declared borrowing rules.

Previously on the same day, calculations indicated there was a £22bn shortfall for the Treasury chief to address, which is at the lower end of expectations.

"It is a shared task between the Bank of England and the administration to continue tackling some of the drivers of inflation," the Chancellor informed reporters in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Commitments and International Issues

While a great deal of the attention has been on probable tax rises, the Treasury chief said the most recent information from the fiscal watchdog had not altered her pledge to election pledges not to increase tax levels on income tax, sales tax or social security contributions.

She attributed an "unpredictable world" with rising geopolitical and trade tensions for the fiscal revenue measures, probably to be directed on those "most able to pay."

Global Trade Tensions

Referring to worries about the United Kingdom's commercial links with China she said: "Our security interests always are paramount."

Recent statement by China to strengthen trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led US President Donald Trump to suggest an further 100% tariff on goods from China, increasing the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary called the Chinese decision "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to participate in its conflict with China, Reeves said she was "very concerned" by China's actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "bad for the international commerce and generates additional headwinds."

"In my view there are fields where we must confront China, but there are also valuable chances to trade with Chinese markets, including financial services and other sectors of the economy. We've got to get that equilibrium right."

The chancellor also confirmed she was working with other major economies "on our own critical minerals plan, so that we are less reliant."

Health Service Medicine Costs and Investment

The Chancellor also admitted that the price the National Health Service pays for pharmaceuticals could rise as a result of current discussions with the US government and its drugs companies, in return for lower tariffs and funding.

A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or scrapping operations in the United Kingdom, with some blaming the modest returns they are receiving.

Recently, the government science advisor said the cost the NHS pays for drugs would have to increase to prevent firms and pharmaceutical investment leaving the UK.

Reeves informed media: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the manner that they are in other EU nations."

"The objective is to ensure that people receiving treatment from the National Health Service are able to receive the top life-saving medicines in the globe. And so we are looking at these issues, and... aiming to attract additional capital into Britain."